Customers need to get their drug to market as quickly as possible and Molly provides that exact opportunity thanks to our new business model. Molly is an innovative medical device that can really take SHL Medical’s products to the next level.
(PRWEB) September 4, 2010
SHL is introducing its first “pre-configured” auto injector to the B2B market for leading biotechnology and pharmaceutical companies. Molly is an intuitive device featuring an ultra-compact design, simplified 2-step operation and a permanently hidden needle. Thanks to collaborative efforts of SHL teams in Sweden, Taiwan and the USA, key development/design work has already been standardized to accelerate speed-to-market for customers. The compact device utilizes state-of-the-art safety and ergonomic features, and is considered by many to be SHL’s next-generation breakthrough auto injector.
SHL plans to officially introduce Molly at the prestigious PDA Conference in Las Vegas, USA on October 18-19, 2010. The phrase “Meet Molly” will be used during the launch and the campaign will focus on the concepts of speed-to-market, compactness, and simplicity. “Customers need to get their drug to market as quickly as possible and Molly provides that exact opportunity thanks to our new business model. Molly is an innovative medical device that can really take SHL Medical’s products to the next level,” commented Lucio Giambattista, Executive Vice President SHL Group.
In addition, Molly will be featured at the PDA Conference in Berlin, Germany on October 26-28, 2010. Mats Persson, SHL’s Vice President of SHL Medical Europe will be speaking at the conference and a display area will be set up during the 3-day event to help targeted audiences better understand how Molly works.
An extensive marketing campaign is now underway and a dedicated website (http://www.meetmolly.com) has been set up to give potential customers a better understanding of how the device works and what makes it unique. At both PDA events a limited number of Molly auto injector sample kits will be available for attendees.
SHL is the world’s largest privately-owned designer, developer and manufacturer of advanced drug delivery devices. We have over 1,500 staff globally (1000 staff in Taiwan), with our primary design centers located in the USA and Sweden and manufacturing centers located in Asia.
SHL supplies auto injectors, pen injectors and inhaler systems to global pharmaceutical and biotech companies. Significant investment in R&D has enhanced our broad pipeline of “next generation” drug delivery systems. These innovative devices include a range of disposable and reusable injectors with fixed or variable dosing, enhanced precision and the ability to accommodate high viscosities.
Our organization consists of three distinct group companies:
Designs, develops and manufactures advanced drug delivery devices for leading pharmaceutical and biotech companies
Develops and manufactures equipment solutions for home, hospital and long term care use
Provides contract manufacturing and engineering services for the production of complex medtech and industrial products
For additional information visit http://www.shl-group.com or contact us at email@example.com
SHL Media Contact
Steven R. Kaufman
+886 932 111 460